Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
416,598,522
-
Number of holders
-
132
-
Total 13F shares, excl. options
-
141,911,833
-
Shares change
-
-18,167,353
-
Total reported value, excl. options
-
$1,889,729,052
-
Value change
-
-$201,269,843
-
Put/Call ratio
-
52.32%
-
Number of buys
-
78
-
Number of sells
-
-72
-
Price
-
$13.32
Significant Holders of CLOVER HEALTH INVESTMENTS, CORP. /DE - Common Stock (CLOV) as of Q2 2021
214 filings reported holding CLOV - CLOVER HEALTH INVESTMENTS, CORP. /DE - Common Stock as of Q2 2021.
CLOVER HEALTH INVESTMENTS, CORP. /DE - Common Stock (CLOV) has 132 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 141,911,833 shares
of 416,598,522 outstanding shares and own 34.06% of the company stock.
Largest 10 shareholders include GREENOAKS CAPITAL PARTNERS LLC (96,331,338 shares), VANGUARD GROUP INC (9,529,811 shares), BAILLIE GIFFORD & CO (5,142,177 shares), FMR LLC (4,260,237 shares), Alphabet Inc. (4,113,742 shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (2,932,060 shares), BlackRock Inc. (2,213,391 shares), PERCEPTIVE ADVISORS LLC (1,500,000 shares), GEODE CAPITAL MANAGEMENT, LLC (1,013,429 shares), and MILLENNIUM MANAGEMENT LLC (1,007,731 shares).
This table shows the top 132 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.